null Skip to main content

✨ Buy more, save 5% Ends

TYROSINE KINASE INHIBITORS in MANAGEMENT of AGGRESSIVE DIFFERENTIATED THYROID CANCER

TYROSINE KINASE INHIBITORS in MANAGEMENT of AGGRESSIVE DIFFERENTIATED THYROID CANCER

$16.37
(No reviews yet) Write a Review
Physical book delivery

Shipping calculated at checkout.

Estimated delivery
Adding to cart… The item has been added
Product Details
Author:
James V. Hennessey MD
Publisher:
Createspace Independent Publishing Platform
Publication Date:
Jun 06, 2014
Number of pages:
80 pages
Binding:
Paperback or Softback
ISBN-10:
1499618719
ISBN-13:
9781499618716

Overview

This small book offers up to the minute information on a serious medical problem- management of differentiated thyroid cancer no longer amendable to surgery or RAI. It covers contemporary initial diagnosis and treatment, making an evidence based decision to move beyond RAI therapy, detailed and practical information on use of tyrosine kinase targeted treatment, and a look at what may come after single-agent TKIs. The authors are all steeped in management of thyroid cancer, including Furio Pacini and Leslie De Groot, Martin Schlumberger, Michael Tuttle and Monica Sabra, Joshua Klopper and Brian Haugen, James Fagin, and James Hennesey. The symposium is presented by www.Thyroidmanager.org and www.Endotext.org, in which pages it was initially published.


  • | Author: James V. Hennessey MD
  • | Publisher: Createspace Independent Publishing Platform
  • | Publication Date: Jun 06, 2014
  • | Number of Pages: 80 pages
  • | Binding: Paperback or Softback
  • | ISBN-10: 1499618719
  • | ISBN-13: 9781499618716

Reviews

0 Reviews

Write a Review

No reviews yet.

Share your experience and help another reader choose their next book.

Discover your next great book

Get new releases, reader favourites, and special offers delivered to your inbox.